EMERYVILLE, Calif. and SHENZHEN, China, October 29, 2026 — Slingshot Bio, the inventor of precision-engineered synthetic cell mimics for use in flow cytometry experimental calibration and control, named Dakewe Biotech Co., Ltd. its exclusive distributor in China. Slingshot Bio will expand adoption of its synthetic cell mimic controls across the biopharma, contract research, academic, and central laboratory industries nationwide through Dakewe’s commercial and technical network.
China’s expanding life sciences sector urgently requires biopharma firms, clinical research institutions, and cell-therapy developers to improve the reproducibility of processes such as cell characterization, immunophenotyping, viability, compensation, spectral unmixing, and quality control. This need is especially critical in multisite product development and large-scale clinical research programs spanning multiple regions. Only Slingshot Bio’s precision-engineered synthetic cell mimics can provide the standardization, consistent performance, and reproducibility of results across instruments, operators, sites, and time that are required.
Slingshot’s cell mimics generate cell-like fluorescence with unparalleled consistency and accuracy, far exceeding the limitations of outdated polystyrene particles and highly variable, fragile biologic controls. Highly efficient, cost-effective, and reproducible flow cytometry workflows are now possible, spanning research, clinical development, and manufacturing. Slingshot mimics have been accepted by the US FDA and EMEA regulatory authorities as manufacturing quality controls, replacing expensive and inconsistent biologic materials.
Founded in 1999 and headquartered in Shenzhen, Dakewe operates from Beijing, Shanghai, Guangzhou, Chengdu, Wuhan, Hong Kong, and more than a dozen additional cities. The company represents more than 100 international life science brands. With nearly three decades of specialization in flow cytometry reagents and instruments, Dakewe brings the technical expertise and nationwide reach to support research, biopharma, and cell-therapy laboratories across China.
“As China’s biopharma, clinical research, and cell-therapy sectors advance, laboratories require controls that can simplify complex and expensive flow cytometry workflows in cell biology,” said Nimisha Srivastava, PhD, Chief Executive Officer of Slingshot Bio. “For decades, laboratories have had to choose between biological controls that introduce variability and inferior plastic particles that do not behave like cells under cytometric examination. Synthetic cell mimics satisfy a long-standing unmet need. Dakewe is unique in possessing the technical expertise and commercial scale to present our products to laboratories across all of China’s life science industries. We are excited to have them on board to expand the launch our five new products into China that will be released before year end.”
“We are honored to be selected as Slingshot Biosciences’s exclusive partner in China. Their synthetic cell-mimic technology’s unmatched reproducibility, long-term stability, and efficiency is a true leap forward in achieving cost-effective flow cytometry quality control and reproducibility,” said Weixue Zhong (Vincent), Chief Technology Officer, Immunology, at Dakewe Biotech. “Dakewe is China’s leading supplier of flow cytometry reagents and instruments, with nearly three decades of hands-on expertise in this field and a nationwide sales network. We possess a unique ability to rapidly deploy this transformative technology to laboratories across the country. Dakewe and Slingshot share a common vision of innovation, precision and scientific excellence. Our collaboration will benefit researchers across China for years to come.”
Slingshot’s synthetic cell mimic products are now available in China exclusively through Dakewe Biotech. Learn more at www.slingshotbio.com.
About Slingshot Biosciences
Slingshot Bio produces precision-engineered synthetic cell mimics for flow cytometry controls, manufactured to ISO reference material standards. Slingshot cell mimic technology has applications in research, development, and manufacturing of new pharmacologic and cell and gene therapies. Thousands of scientists in academia, government, and industry laboratories around the globe are using Slingshot’s cell mimic products to replace the variable and fragile reference materials that limit the accuracy and reproducibility of flow cytometry analysis. Synthetic cell mimics deliver unmatched stability and consistency. Learn more at slingshotbio.com.
About Dakewe Biotech
Founded in 1999 and headquartered in Shenzhen, Dakewe Biotech Co., Ltd. is a leading supplier of life science reagents, scientific instruments, and medical equipment in China. Dakewe represents more than 100 international biotechnology brands across immunology, cell biology, and molecular biology, and develops and manufactures its own immunoassay and histopathology product lines. Learn more at bio-city.net.
Media Contact: Josh Haydon, Head of Marketing, marketing@slingshotbio.com
Stay updated
Subscribe to receive the latest press releases, company news, and product announcements from Slingshot Biosciences.
